Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Carlsbad, CA
SEC filing record 1 source field available
Fiscal year end
31 December
IONIS PHARMACEUTICALS INC has filed 2,657 SEC EDGAR filings since 12 Jun 1996

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page
25
Current page
40
4

PRIMARY DOCUMENT

Filing date
17 Jun 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-19125

IONIS PHARMACEUTICALS INC 10-Q 3-31-2020

Filing date
06 May 2020
Reporting date
31 Mar 2020
Next action
Verify source filing
DEFA14A File 000-19125

DEFA14A

Filing date
24 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-19125

DEF 14A

Filing date
24 Apr 2020
Reporting date
04 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
17 Apr 2020
Reporting date
15 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Mar 2020
Reporting date
25 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
27 Mar 2020
Reporting date
17 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-19125

CT ORDER filing

Filing date
24 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-19125

CT ORDER filing

Filing date
24 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-19125

CT ORDER filing

Filing date
24 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-19125

CT ORDER filing

Filing date
24 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-19125

CT ORDER filing

Filing date
24 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Mar 2020
Reporting date
19 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Mar 2020
Reporting date
17 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2020
Reporting date
29 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2020
Reporting date
29 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2020
Reporting date
29 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2020
Reporting date
29 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2020
Reporting date
29 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2020
Reporting date
29 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-19125

IONIS PHARMACEUTICALS, INC. 10-K 12-31-2019

Filing date
02 Mar 2020
Reporting date
31 Dec 2019
Next action
Verify source filing
SC 13G/A File 005-41771

SC 13G/A

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .